Skip to main content
. 2022 Dec 6;2022(12):CD013601. doi: 10.1002/14651858.CD013601.pub2

IRCT138811212779N2.

Methods Parallel RCT (double blind)
Participants HD patients
Interventions L‐carnitine (IV): 1000 mg at each dialysis session/ubiquinone (oral) 100 mg/day
Outcomes Cardiovascular risk factors
Notes Protocol registration only; current status is unknown